GlassScriptPhysician profile
Robert Michael Liebman
NPI 1760844427
$3,969.29
in general payments reported to CMS, 2019-2025
17 companies · $437 in 2025
The $437 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.43 · 2021: $1,197 · 2022: $77.33 · 2023: $1,942 · 2024: $304 · 2025: $437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,537 · Food and Beverage: $1,147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,536.50 |
| Food and Beverage | $1,146.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,492.03 | 2023-2024 | Na |
| Inspire Medical Systems, INC. | $819.13 | 2021 | |
| Kls-Martin L.P. | $442.72 | 2023-2024 | |
| Medical Device Business Services, INC. | $365.09 | 2021 | |
| Depuy Synthes Sales INC. | $320.68 | 2022-2025 | Matrixmandible, Matrixmidface, Trumatch |
| Tactile Systems Technology INC | $121.87 | 2025 | Nimbl, Flexitouch Plus |
| Atos Medical INC | $109.19 | 2024 | Provox Life Home Hme |
| Aroa Biosurgery Incorporated | $80.65 | 2025 | |
| Pentax of America, INC. | $52.72 | 2023 | N/A |
| Straumann USA LLC | $37.24 | 2025 | |
| Polynovo North America LLC | $31.97 | 2023 | |
| Exelixis INC. | $31.80 | 2023 | Cabometyx |
| Smith+Nephew, INC. | $15.80 | 2025 | Pico |
| Glaxosmithkline, LLC. | $13.63 | 2025 | Nucala |
| Optinose US, INC. | $12.82 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $11.43 | 2019 | |
| Access Pro Medical, LLC | $10.52 | 2023 | Matriderm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Liebman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.